VIA

Virtus Investment Advisers Portfolio holdings

AUM $349M
1-Year Est. Return 25.41%
This Quarter Est. Return
1 Year Est. Return
+25.41%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$296M
AUM Growth
-$72M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
512
New
Increased
Reduced
Closed

Top Buys

1 +$2.01M
2 +$1.82M
3 +$1.75M
4
CSCO icon
Cisco
CSCO
+$1.7M
5
STT icon
State Street
STT
+$1.69M

Sector Composition

1 Financials 33.24%
2 Healthcare 17.43%
3 Technology 12.41%
4 Industrials 9.1%
5 Consumer Discretionary 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLAD icon
176
Gladstone Capital
GLAD
$431M
$597K 0.2%
22,133
-3,137
MPV
177
Barings Participation Investors
MPV
$214M
$572K 0.19%
28,448
-10,501
BCIC
178
BCP Investment Corp
BCIC
$167M
$546K 0.18%
43,619
+5,775
CRSP icon
179
CRISPR Therapeutics
CRSP
$5.01B
$524K 0.18%
10,765
+2,860
MRCC icon
180
Monroe Capital Corp
MRCC
$140M
$523K 0.18%
82,292
+6,693
OFS icon
181
OFS Capital
OFS
$67M
$523K 0.18%
61,914
-16,664
MAIN icon
182
Main Street Capital
MAIN
$5.23B
$518K 0.18%
8,758
-624
WHF icon
183
WhiteHorse Finance
WHF
$164M
$508K 0.17%
58,256
-74,765
IONS icon
184
Ionis Pharmaceuticals
IONS
$11.6B
$493K 0.17%
12,476
+2,775
OXSQ icon
185
Oxford Square Capital
OXSQ
$154M
$492K 0.17%
220,488
-11,097
BBIO icon
186
BridgeBio Pharma
BBIO
$12.8B
$484K 0.16%
11,208
-1,770
ALNY icon
187
Alnylam Pharmaceuticals
ALNY
$59.3B
$476K 0.16%
1,459
-8
EXEL icon
188
Exelixis
EXEL
$11.2B
$469K 0.16%
10,637
+428
ARDX icon
189
Ardelyx
ARDX
$1.42B
$468K 0.16%
119,461
+50,946
TBPH icon
190
Theravance Biopharma
TBPH
$881M
$462K 0.16%
41,884
+5,505
INSM icon
191
Insmed
INSM
$41.2B
$462K 0.16%
4,587
-399
MIRM icon
192
Mirum Pharmaceuticals
MIRM
$3.67B
$461K 0.16%
9,066
+574
AUPH icon
193
Aurinia Pharmaceuticals
AUPH
$2.02B
$457K 0.15%
53,997
+16,946
MDGL icon
194
Madrigal Pharmaceuticals
MDGL
$12B
$452K 0.15%
1,495
+307
BNTX icon
195
BioNTech
BNTX
$24.8B
$451K 0.15%
4,236
+1,260
ASND icon
196
Ascendis Pharma
ASND
$12.5B
$449K 0.15%
2,600
-147
MRNA icon
197
Moderna
MRNA
$9.68B
$448K 0.15%
16,248
+7,863
REGN icon
198
Regeneron Pharmaceuticals
REGN
$72.9B
$447K 0.15%
852
+366
NBIX icon
199
Neurocrine Biosciences
NBIX
$14.4B
$447K 0.15%
3,555
+722
UTHR icon
200
United Therapeutics
UTHR
$20.1B
$446K 0.15%
1,553
+559